Category: Uncategorized

Read More

PreveCeutical Announces the Successful Engineering & Cell-Based Efficacy Screening of its Smart-siRNA Constructs for its Dual Gene Therapy Research Program

PreveCeutical Medical Inc. (CSE:PREV, OTCQB: PRVCF, FSE:18H) (the “Company” or “PreveCeutical”), is pleased to provide an update on its dual gene therapy program, an important and fundamental aspect of which involves the design, synthesis and screening […]